From specific doping to general doping behaviors: Notes;Du dopage en particulier aux conduites dopantes en général: Le point sur les connaissances

Psychotropes

Volumn 8, Issue 3-4, 2002, Pages 9-22

  Binsinger, Caroline ^a   Friser, Audrey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68449085513     PISSN: 12452092     EISSN: None     Source Type: Journal    
DOI: 10.3917/psyt.083.0009     Document Type: Review

References (30)

1. BECK F., LEGLEYE S., PERETTI-WATEL P., Regard sur la fin de l'adolescence. Consommations de produits psychoactifs dans l'enquête, ESCAPAD 2000, Paris, OFDT, 2000.
2. BROWN W., Ethics, drugs and sport, J Philosophy Sport, 1980, 7, 15-23.
3. CHOQUET M., LEDOUX S., HASSLER C. et al., Consommations de substances psychoactives chez les 14-18 ans scolarisés : premiers résultats de l'enquête ESPAD 1999, évolution 1993-1999, Paris, OFDT, 2000.
4. DEROANNE R., PIRNAY F., PETIT J.-M., Amphétamine, aptitude physique et performance, Rev Med Liège, 1979, 5, 168-170.
5. FAIGENBAUM A. D., ZAICHKOWSKY L. D., GARDNER D. E., MICHELI L. J., Anabolic steroid use by male and female middle school students, Pediatrics, 1998, 101, 916-917.
6. GOLDBERG L., BENT R., BOSWORTH E., Anabolic steroid education and adolescent : do scare tactics work ?, Pediatrics, 1999, 87, 283-286.
7. GOLDBERG L., ELLIOT D., CLARKE G.N. et al., Effects of a multidimentional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroid (ATLAS) program, J Am Med Assoc, 1996, 276, 1555-1562.
8. GOLDBERG L., MACKINNON D.P., ELLIOT D.L. et al., The adolescents training and learning to avoid steroids program : preventing drug use and promoting health behaviors, Arch Pediatr Adolesc Med, 2000, 4, 332-338.
9. HAGUENOER J.-M., HANNOTHIAUX M.H., LAHAYE-ROUSSEL M.C., FONTAINE B., LEGRAND P.M., SHIRALI P. et al., Prévalence des comportements toxicophiles en milieu professionnel : une étude dans la région Nord-Pas-de-Calais, Bull Ordre Med, 1997, 80, 11-15.
10. HOLMA P., Effects of an anabolic steroid (methandienon) on central and peripheral blood flow in well-trained males athletes, Ann Clin Res, 1977, 9, 215-221.
11. HUGUES P.H., BRANDENBURG N., BLADWIN D.C., STORR C.L., WILLIAMS K.M., ANTHONY J.-C., SHEEHAN D.V., Prevalence of substance use among US physicians, J Am Med Assoc, 1992, 17, 333-2339.
12. KINDLUNDH A.M., ISACSON D.G., BERGLUND L., NYBERG F., Doping among high school students in Uppsala Sweden : a presentation of the attitudes distribution side effects and extent of use, Scan J Soc Med, 1998, 26, 71-74.
13. LAURE L., LECERF T., Prévention du dopage sportif chez les adolescents : à propos d'une action évaluée d'éducation pour la santé, Arch Ped, 1999, 6, 849-854.
14. LAURE P., Doping in amateur adult athletes aged 15 or over, J Perf Enhancing Drugs, 1998, 2, 16-21.
15. LAURE P., Dopage et société, Paris, Ellipses, 2000.
16. LEDOUX S., CHOQUET M., MANFREDI R., Self-reported use of drugs for sleep or distress among French adolescents, J Adolesc Health, 1995, 15, 495-502.
17. LEDOUX S., SIZARET A., HASSLER C., CHOQUET M., Consommation de substances psychoactives à l'adolescence. Revue des études de cohorte, Alcoologie et addictologie, 2000, 22 (1), 19-40.
18. LONGHTON S.J., RUHLING R.O., Human strength and endurance response to anabolic steroid and training, J Sports Med Phys Fitness, 1977, 17, 285-296.
19. MELIA P., PIPE A., GREENBERG L., The use of anabolic-androgenic steroids by canadian students, Clin J Sport Med, 1996, 6, 9-14.
20. Ministère de la Jeunesse et des Sports, Contrôles antidopage en France, Présentation des statistiques, 2001.
21. OHAERI J., IKPEME E., IKWUAGWU U., ZAMANI A., ODEJIDE O.A., Use and awareness of effects of anabolic steroids and psychoactive substances among a cohorte of Nigerian professionnal sports men and women, Hum Psychopharmacol, 1993, 8, 429-432.
22. PARQUET P.-J., Pour une prévention de l'usage des substances psychoactives. Usage, usage nocif, dépendance, Vanves, CFES, 1998.
23. PIDETCHA P., CONGPUONG P., PUTRIPRAWAN T., REKAKANAKUL R., SUWANTON L., TANTRARONGROJ S., Screening for urinary amphetamine in truck drivers and drugs addicts, J Med Assoc Thai, 1995, 78, 554-558.
24. POTTIER C., GEORGELIN R., COUEDIC C., Psychose hallucinatoire par intoxication amphétaminique, Ann Med Physio, 1953, 11, 220-224.
25. SCARPINO V., ARRIGO A., BENZI G., GARATTINI S., LA VECCHIA C., BERNARDI L.R., Evaluation of prevalence of doping among italian athletes, Lancet, 1990, 336, 1048-1050.
26. SMITH G.M., BEECHER H.K., Amphetamine sulfate on athletic performance. I-Objective effects, J Am Med Assoc, 1959, 170, 542-557.
27. TANNER S. M., MILLER D. W., ALONGI C., Anabolic steroid use by adolescents : prevalence motives and knowledge of risks, Clin J Sport Med, 1995, 2, 108-115.
28. VAILLE C., Poisons d'actualité, Presse Med, 1966, 74, 2117-2119.
29. WHITEHEAD R., CHILLAG S., ELLIOTT D., Anabolic steroid use among adolescents in a rural state, J Fam Pract, 1992, 4, 401-405.
30. YESALIS C.E., BARSUKIEWICZ C.K., KOPSTEIN A.N., BAHRKE M.S., Trends in anabolic-androgenic steroid use among adolescents, Arch Pediatr Adolesc Med, 1997, 151, 1197-1206.